SON becomes the sponsor of the Master Innovative Drugs for the 2024-2025 academic year.
SON is immensely proud to announce its role as the sponsor of the Master Innovative Drugs, a pioneering program in pharmaceutical sciences.
At SON, education and knowledge transfer have always been at the core of our mission. This new collaboration aligns perfectly with the DNA of our company, and we are very excited about it!
An exceptional master’s degree at the heart of innovation
The international Master Innovative Drugs, co-directed by Arnaud Beduneau and Bertrand Collin, welcomes students from all over the world. These high-level students often hold a master’s degree or a PhD upon entering the program. Their diverse backgrounds bring an undeniable cultural dimension to the program.
Founded in Dijon, this master’s program aims to train professionals who will design tomorrow’s treatments.
Professor Anthony Romieu (ICMUB) and Dr. Romain Douhard contribute to the organization and delivery of the program, alongside leading faculty members. Without their expertise and dedication, this exceptional training could not exist.
Exceptional partners in the service of health
The program benefits from the support of leading institutional partners such as the University of Burgundy and the University of Franche-Comté, with their Health Sciences faculties (Dijon) and Health faculties (Besançon).
Support from LabEx LIPSTIC and EquipEx IMAPPI, as well as the graduate schools One Health and Intherapi, allows this master’s program to offer exceptional facilities and opportunities. Dijon Metropole and Santenov also provide essential support by strengthening local synergies in favor of health innovation.
Lastly, partner laboratories and hospitals such as UMR Right, UMR CTM, ICMUB, CGFL, and UMR Chrono-environnement play a key role in the success of the program by offering students an environment conducive to innovation and applied research.
To learn more about the Master Innovative Drugs, we invite you to visit the dedicated website here.
To know more about the SON activities, see here.